12/01/2025
๐ฆ๐๐ฟ๐ฒ๐ป๐ด๐๐ต๐ฒ๐ป๐ถ๐ป๐ด ๐๐ฐ๐ฎ๐ฑ๐ฒ๐บ๐ถ๐ฐ ๐ฎ๐ป๐ฑ ๐ฅ๐ฒ๐๐ฒ๐ฎ๐ฟ๐ฐ๐ต ๐ง๐ถ๐ฒ๐: ๐ฆ๐๐ถ๐๐ ๐ฃ๐ต๐ฎ๐ฟ๐บ๐ฎ ๐ฅ๐ฒ๐๐ฒ๐ฎ๐ฟ๐ฐ๐ต ๐๐ฎ๐ฏ๐ผ๐ฟ๐ฎ๐๐ผ๐ฟ๐ถ๐ฒ๐, ๐๐ป๐ฐ. ๐ฉ๐ถ๐๐ถ๐๐ ๐๐ฃ๐จ ๐๐ฎ๐๐ถ๐๐ฒ
An exploratory meeting with Swiss Pharma Research Laboratories, Inc. marked a significant milestone for Lyceum of the Philippines University (LPU) Cavite as it explored potential collaborations in research and development. The visit was graced by Mr. Benjamin Tantiansu, President and CEO of Swiss Pharma Research Laboratories, Inc., accompanied by Ms. Natalie Gerundio, the companyโs business consultant. They were warmly welcomed by Dr. Maria Teresa O. Pilapil, Vice President for Administration; Dr. Mark Irvin C. Celis, Vice President for Academic Affairs; and Dr. Catherine Cababa, Dean of the College of Allied Medical Sciences.
Held on January 9, 2025, the meeting served as a platform to discuss the scope of collaboration between Swiss Pharma and LPU Cavite. Discussions focused on fostering partnerships aligned with the universityโs goals of academic excellence and innovation in research. Key initiatives included joint research projects, faculty and student development. Specific plans were outlined to facilitate faculty immersion programs for enhanced industry exposure and practical knowledge and to provide on-the-job training opportunities for BS Pharmacy and BS Biology students.
Dr. Pilapil emphasized the importance of bridging academia and industry through such partnerships. Dr. Celis highlighted how this collaboration aligns with LPU Cavite's vision of producing globally competitive graduates, while Dr. Cababa expressed optimism about its potential to elevate the College of Allied Medical Sciences' research capabilities and curriculum.
Mr. Tantiansu and Ms. Gerundio conveyed their enthusiasm for the partnership, commending LPU Caviteโs forward-thinking approach and commitment to innovation. They also underscored Swiss Pharmaโs dedication to advancing research that addresses global health challenges.
This exploratory meeting marks the beginning of a promising partnership. Both parties expressed intent to further discussions and finalize plans in the coming months, ensuring mutual growth and impactful contributions to the pharmaceutical and academic sectors.
As LPU Cavite continues to strengthen its ties with global institutions, this collaboration with Swiss Pharma Research Laboratories, Inc. signifies a step forward in achieving excellence in education, research, and community engagement. Together, they aim to make significant strides in shaping the future of healthcare and allied sciences.